Hamm&wittkopp Patentanwälte Partmbb patent opposition analysis

The comprehensive analysis of Hamm&wittkopp Patentanwälte Partmbb opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Hamm&wittkopp Patentanwälte Partmbb

Patent NumberTitleApplicantOpposition DateOpposition Company
Ribociclib TabletNOVARTIS AGAug 12, 2026STADA ARZNEIMITTEL
Solid Forms And Formulations Of (S)-4-(8-Amino-3-(1-(But-2-Ynoyl)Pyrrolidin-2-Yl)Imidazo[1,5-A]Pyrazin-1-Yl)-N-(Pyridin-2-Yl)BenzamideACERTA PHARMA B.V.Aug 11, 2026HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla GeneAMICUS THERAPEUTICS, INC.Aug 3, 2026HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
Methods Of Treating And/Or Preventing Actinic KeratosisATNX SPV, LLCJul 29, 2026MIBE
Method Of Treating Cancer Using Selective Estrogen Receptor ModulatorsDUKE UNIVERSITYJul 20, 2026SYNTHON
Microporous Zirconium Silicate For Treating HyperkalemiaZS PHARMA, INCJun 17, 2026HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
Method Of Synthesizing Thyroid Hormone Analogs And Polymorphs ThereofMADRIGAL PHARMACEUTICALS, INC.Jun 9, 2026SYNTHON
Pharmaceutical Formulation Comprising EzetimibeASSIA CHEMICAL INDUSTRIES LTD.Jun 3, 2026HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
Methods Of Selecting A Treatment For Cancer PatientsNOVARTIS AGJun 3, 2026STADA ARZNEIMITTEL
Migalastat Formulations Having Improved PharmacokineticsAMICUS THERAPEUTICS, INC.Jun 2, 2026HAMM&WITTKOPP PATENTANWÄLTE PARTMBB